A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
The purpose of this study is to determine if vebicorvir (VBR, ABI-H0731) in combination with AB-729 is safe and effective in participants with chronic hepatitis B infection (cHBV) receiving a standard of care nucleos(t)ide/reverse transcriptase inhibitor (SOC NrtI).
Epistemonikos ID: 2d80c7fe893e4f8c89e5e76ecea65a3e3b7970d8
First added on: Nov 24, 2021